论文部分内容阅读
本文对我院1995年2～7月100例腮脑住院患儿分别用双黄连和利巴韦林治疗,并加以比较,结果显示用双黄连组发热持续天数比用利巴韦林组缩短,统计学上有非常显著差异(t=2.60,P<0.01);用双黄连组神经系统症状持续天数比用利巴韦林组稍缩短,但统计学上无显著差异(t=1.19,P>0.05)。停药后3天对两组治疗前EEG有异常者进行复查,显示EEG的恢复率在统计学上无显著差异(t=0.745,P>0.05)。作者认为用双黄连治疗腮脑是安全有效的。
This article from January 1995 to July 1995, 100 cases of in vitro cheilitis hospitalized children were treated with shuanghuanglian and ribavirin, and compared, the results showed that with shuanghuanglian group fever than with ribavirin group shortened, There was a statistically significant difference (t = 2.60, P <0.01). The duration of neurological symptoms in Shuanghuanglian group was slightly shorter than that in the ribavirin group, but there was no significant difference (t = 1.19, P> 0.05). Three days after discontinuation of the two groups before treatment, EEG abnormalities were reviewed, showing no statistically significant difference in the recovery rate of EEG (t = 0.745, P> 0.05). The authors believe that Shuanghuanglian treatment of brain is safe and effective.